Advertisement
Advertisement

SBFM

SBFM logo

Sunshine Biopharma Inc.

2.28
USD
Sponsored
-0.15
-6.17%
Jun 09, 16:00 UTC -4
Closed
exchange

After-Market

2.20

-0.08
-3.55%

Sunshine Biopharma Inc. Profile

About

Sunshine Biopharma Inc. is a pharmaceutical company. It focused on the research, development and commercialization of oncology and antiviral drugs. Sunshine Biopharma Inc. is based in MONTREAL.

Info & Links

CEO

Steve N. Slilaty

Headquarters

333 LAS OLAS WAY,CU4 SUITE 433
FORT LAUDERDALE, FL 33301, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://sunshinebiopharma.com

Auditor

M&K CPAS, PLLC

Share holders

117

Employees

50

Sunshine Biopharma Inc. Statistics

Valuation Measures

Market Capitalization2

3.55M

Enterprise Value

-3.36M

Enterprise Value/EBITDA(ttm)

0.79

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.14

Price to Book(mrq)

0.22

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

32.98%

Operating Margin(ttm)

-16.06%

Profit Margin(ttm)

-15.99%

Return on Equity(ttm)

-24.96%

Return on Invested Capital(ttm)

-24.93%

Return on Assets(ttm)

-19.46%

Income Statement

Revenue(ttm)

35.49M

Revenue Per Share(ttm)

7.09

Gross Profit(ttm)

11.71M

EBITDA(ttm)3

-4.23M

Net Income Available to Common(ttm)

-6.04M

Diluted EPS(ttm)

-1.48

Share Statistics

Beta (5Y Monthly)

1.47

52-Week Change

-84.90%

S&P 500 52-Week Change

22.99%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

5.01M

Dividend Yield

0.00%

Float4

4.90M

% Held by Insiders

0.04%

% Held by Institutions

41.98%

Balance Sheet

Total Cash(mrq)

6.91M

Total Cash Per Share(mrq)

1.38

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.20%

Quick Ratio(mrq)

2.09%

Book Value Per Share(mrq)

5.31

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.82

Free Cash Flow(ytd)

-3.88M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement